PROPRANOLOL HYDROCHLORIDE by Novartis is clinical pharmacology general propranolol is a nonselective beta-adrenergic receptor blocking agent possessing no other autonomic nervous system activity. Approved for common migraine headache, tremor associated with parkinsonism, the management of hypertension and 6 more indications.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY General Propranolol is a nonselective beta-adrenergic receptor blocking agent possessing no other autonomic nervous system activity. It specifically competes with beta-adrenergic receptor agonist agents for available receptor sites. When access to beta-receptor sites is…
Worked on PROPRANOLOL HYDROCHLORIDE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer